Monotherapy May Be Suboptimal for Severe Bacteremic Pneumococcal Pneumonia
Top Cited Papers
Open Access
- 13 August 2001
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 161 (15) , 1837-1842
- https://doi.org/10.1001/archinte.161.15.1837
Abstract
THE INTRODUCTION of antibiotic agents dramatically reduced mortality from pneumococcal pneumonia.1,2 However, the mortality rate from bacteremic pneumococcal community-acquired pneumonia (CAP) has shown little improvement in the past 3 decades, remaining between 19% and 28% depending on the population and institution studied.3-5Keywords
This publication has 24 references indexed in Scilit:
- Antimicrobial Resistance in Respiratory Tract Pathogens: Results of an International Surveillance StudyChemotherapy, 2000
- Bacteremic pneumococcal pneumonia in one American city: a 20-year longitudinal study, 1978–1997The American Journal of Medicine, 1999
- Community‐Acquired Pneumonia in Adults: Guidelines for ManagementClinical Infectious Diseases, 1998
- Streptococcus pneumoniae Bacteremia in a Community HospitalChest, 1998
- Atypical pneumonia in the Nordic countries: aetiology and clinical results of a trial comparing fleroxacin and doxycycline. Nordic Atypical Pneumonia Study GroupJournal of Antimicrobial Chemotherapy, 1997
- A Prediction Rule to Identify Low-Risk Patients with Community-Acquired PneumoniaNew England Journal of Medicine, 1997
- Community acquired pneumonia: aetiology and usefulness of severity criteria on admission.Thorax, 1996
- Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients.Thorax, 1996
- Resistance to Penicillin and Cephalosporin and Mortality from Severe Pneumococcal Pneumonia in Barcelona, SpainNew England Journal of Medicine, 1995
- THE EFFECT OF ANTIBIOTICS (PENICILLIN, AUREOMYCIN, AND TERRAMYCIN) ON THE FATALITY RATE AND INCIDENCE OF COMPLICATIONS IN PNEUMOCOCCIC PNEUMONIA. A COMPARISON WITH OTHER METHODS OF THERAPYThe Lancet Healthy Longevity, 1951